Best practice guidance for ensuring more women receive a timely, accurate diagnosis and effective treatment via post menopausal bleeding clinics is now available to gynaecology teams. GIRFT has developed a supplementary guide, focussing on optimising post menopausal bleeding clinics, to be read in conjunction with the BMS joint guideline on the management of unscheduled [...]
Beyond the Foundations, organised by The Menopause Course in collaboration with the British Menopause Society, is a one-day meeting for nurses currently working in menopause care. It will build on prior menopause education and/or clinical experience to offer an update on key topics in this area of women’s health. This is a face-to-face meeting [...]
As the specialist authority for menopause and post reproductive health in the UK, the British Menopause Society plays a pivotal role in shaping best-practice menopause care. The British Menopause Society strongly encourages healthcare professionals to practice within national and international guidelines. The British Menopause Society has developed a comprehensive education programme for healthcare professionals and [...]
The British Menopause Society, in partnership with the British Gynaecological Cancer Society, has produced a new guideline on the management of menopausal symptoms following treatment of gynaecological cancer. The guideline provides information to support healthcare professionals managing women treated for gynaecological cancer.
An editorial, written by BMS Chair, Professor Janice Rymer, and BMS Immediate Past Chair, Dr Paula Briggs, was published in the British Journal of General Practice on Friday. The editorial Managing the menopause in general practice: a tale of pragmatism, caution, and optimism questions the current message in the media that all symptoms in women [...]
A new factsheet on the Management of unscheduled bleeding on HRT has been published on the Women’s Health Concern website. This factsheet provides a summary version of the BMS joint guideline on the management of unscheduled bleeding on hormone replacement therapy (HRT) for those who use HRT and who may have unscheduled bleeding. The [...]
We welcome the announcement that the National Institute for Health and Care Excellence (NICE) has approved a new drug, Abaloparatide, for use by the NHS in England. It will be available to eligible patients within three months. Abaloparatide increases bone density by stimulating the cells that make new bone and it has been recommended for [...]
In the past few weeks, there has been a significant increase in media attention for more women to be prescribed testosterone. Some of these articles have been written by lay people and it appears that the information provided has been misrepresented to support personal opinion. Misinformation risks medicalising a normal life stage and render [...]
A quick-look summary of the BMS joint guideline on the management of unscheduled bleeding on hormone replacement therapy (HRT) has been issued by GIRFT. This summary will support clinical decision-making and help to ensure that women receive the right care. GIRFT was among the contributors to the detailed BMS guidance on the management of [...]
Researchers at the UCL Menopause Mind Lab are calling for healthcare professionals (HCPs) interested in cognitive health during the menopause transition to participate in a focus group study. HCPs must be currently working in this area of health in the UK. A Zoom session is planned for Friday 26 July from 1200-1300. If you [...]
